Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 crawled date : 2022 - 01 - 18 save search
Sun Life introduces employer community to ThrivePass to help manage workplace vaccine verification and testing for COVID-19
Published: 2022-01-18 (Crawled : 19:00) - prnewswire.com
SLF 4 d | $51.85 0.54% 0.02% 280K
|
Finance
|
| O: 0.88%
H: 0.0%
C: -1.77%
covid-19 covid work test vaccine
APDN Announces Continued Momentum in COVID-19 Testing Demand
Published: 2022-01-18 (Crawled : 16:00) - adnas.com
APDN | $0.2888 -12.49% -14.27% 810K
|
Commercial Services
|
| O: -0.25%
H: 1.99%
C: 0.5%
covid-19 ema covid test
Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
ADTX | $2.285 2.93% 2.84% 26K
|
Health Technology
|
| O: 2.73%
H: 1.66%
C: -6.11%
covid-19 fda covid authorization test merge antibody emergency use authorization
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler)
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 2.35%
H: 0.0%
C: 0.0%
covid-19 health phase 2 trial covid brazil
Global COVID-19 EIA/ELISA Medical Devices Market Landscape Report 2021: Comparative Analysis of the Products at Various Stages of Development
Published: 2022-01-18 (Crawled : 14:00) - prnewswire.com
OCDX | News | $17.63 0.45%
|
|
| O: -2.65%
H: 1.39%
C: -0.91%
IPA | $1.24 -0.8% -0.81% 39K
|
Professional, Scientific, and T...
|
| O: 0.32%
H: 2.22%
C: -1.59%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -2.15%
H: 0.0%
C: 0.0%
TECH | $63.675 1.39% 1.37% 1.2M
|
Health Technology
|
| O: -4.04%
H: 0.39%
C: -1.01%
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 7.34%
H: 0.0%
C: 0.0%
covid-19 ces device covid report
NRx Pharmaceuticals Announces Expansion of ZYESAMI® (aviptadil) US Expanded Access and Right to Try Programs for Patients with COVID-19 Respiratory Failure who have Exhausted All Approved Treatments
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
NRXP 5 d | $3.1 3.33% 3.23% 110K
|
Manufacturing
|
| O: -0.57%
H: 0.0%
C: -8.68%
covid-19 zyesami treatment aviptadil als expansion respiratory covid
Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -0.4%
H: 0.0%
C: -0.58%
MRK | $126.88 -0.05% -0.13% 7.5M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
covid-19 covid molnupiravir antiviral
Molecular Partners Finalizes License Agreement with Novartis for Ensovibep for COVID-19
Published: 2022-01-18 (Crawled : 07:00) - globenewswire.com
MOLN | $3.88 -3.54% 520
|
Professional, Scientific, and T...
|
| O: -8.83%
H: 0.4%
C: -4.19%
covid-19 novartis ensovibep license covid molecular
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.